Patient Satisfaction Study of BOTOX® Cosmetic in the Treatment of Moderate to Severe Frown Lines

Completed · Phase 4 · Has a placebo group

Conditions studied: Glabellar Frown Lines

In brief

This was a pilot study to observe patient satisfaction with BOTOX® Cosmetic treatment in glabellar rhytides (frown lines) using a new treatment satisfaction measure.

Key facts

Study ID

NCT01391312

Run by

Allergan

People needed

40

Starts

2011-06-01

Expected to finish

2011-10-01

Last updated by the study team

2012-09-25

Who can join

Age: 18 and older, up to 65. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Moderate to severe glabellar wrinkles (frown lines)

You may not qualify if…

• Previous treatment with botulinum toxin therapy of any serotype
• Facial non-ablative resurfacing laser or light treatment, microdermabrasion, or superficial peels within 3 months
• Any facial cosmetic procedure with medium depth to deep facial chemical peels (e.g., trichloroacetic acid and phenol), mid-facial or periorbital laser skin resurfacing or permanent make-up within 6 months
• Mid-facial or periorbital treatment with non-permanent soft tissue fillers
• Subjects planning a facial cosmetic procedure or visible scars
• Previous cosmetic surgery to the upper face(e.g., prior periorbital surgery, facial lift, brow lift, eyelid lift or eyebrow surgery)
• Diagnoses of Myasthenia Gravis, Eaton-Lambert Syndrome, Amyotrophic Lateral Sclerosis
• History of facial nerve palsy
• A planned extended absence during the study

Where it is running

• Study site — East Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.